Skip to main content

previous disabled Page of 3
and
  1. No Access

    Article

    Immunohistological analysis of B7-H4, IDO1, and PD-L1 expression and tumor immune microenvironment based on triple-negative breast cancer subtypes

    B7 homolog 4 (B7-H4) and indoleamine 2,3-dioxygenase (IDO1) are factors involved in the inhibition of antitumor activity and are new therapeutic targets for immune checkpoint therapy. Our study aimed to simultane...

    Fumiaki Sanuki, Yuka Mikami, Hirotake Nishimura, Yoshinori Fujita in Breast Cancer (2023)

  2. Article

    Open Access

    Primary endometrioid carcinoma of the uterosacral ligament arising from deep infiltrating endometriosis 6 years after bilateral sal**o-oophorectomy due to atypical proliferative endometrioid tumor of the ovary: a rare case report

    Endometriosis can potentially lead to the development of a malignant tumor. Most malignant tumors arising from the endometriosis originate from the ovarian endometrioma, whereas those arising from extragonadal...

    Yoshiaki Ota, Kuniaki Ota, Toshifumi Takahashi in World Journal of Surgical Oncology (2020)

  3. Article

    Open Access

    Targeted next-generation sequencing assays using triplet samples of normal breast tissue, primary breast cancer, and recurrent/metastatic lesions

    Next-generation sequencing (NGS) has shown that recurrent/metastatic breast cancer lesions may have additional genetic changes compared with the primary tumor. These additional changes may be related to tumor ...

    Toshiaki Akahane, Naoki Kanomata, Oi Harada, Tetsumasa Yamashita in BMC Cancer (2020)

  4. No Access

    Article

    Multispectral quantitative immunohistochemical analysis of tumor-infiltrating lymphocytes in relation to programmed death-ligand 1 expression in triple-negative breast cancer

    Programmed death-ligand 1 (PD-L1) expression on immune cells (ICs) is a predictive marker for PD-L1 checkpoint blockade in patients with triple-negative breast cancer (TNBC). However, the level of PD-L1 expres...

    Tomoharu Sugie, Eiichi Sato, Minoru Miyashita, Rin Yamaguchi in Breast Cancer (2020)

  5. Article

    Correction to: Histological classification of breast tumors in the General Rules for Clinical and Pathological Recording of Breast Cancer (18th edition)

    In the original publication of the article, the author group and acknowledgements were published incorrectly.

    Hitoshi Tsuda, Koichiro Tsugawa, Futoshi Akiyama, Rie Horii in Breast Cancer (2020)

  6. Article

    Open Access

    CD1d- and PJA2-related immune microenvironment differs between invasive breast carcinomas with and without a micropapillary feature

    Invasive micropapillary carcinoma (IMPC) of the breast is characterized by its unique morphology and frequent nodal metastasis. However, the mechanism for development of this unique subtype has not been clearl...

    Naoki Kanomata, Junichi Kurebayashi, Yoshikazu Koike, Rin Yamaguchi in BMC Cancer (2019)

  7. No Access

    Article

    Proposal for a Risk-Based Categorization of Uterine Carcinosarcoma

    To propose a categorization model of uterine carcinosarcoma (UCS) based on tumor cell types (carcinoma and sarcoma) and sarcoma dominance.

    Koji Matsuo, Yutaka Takazawa, Malcolm S. Ross in Annals of Surgical Oncology (2018)

  8. No Access

    Article

    Significance of Lymphovascular Space Invasion by the Sarcomatous Component in Uterine Carcinosarcoma

    The aim of this study was to examine the significance of lymphovascular space invasion (LVSI) with a sarcomatous component on the tumor characteristics and clinical outcomes of women with uterine carcinosarcom...

    Koji Matsuo, Yutaka Takazawa, Malcolm S. Ross in Annals of Surgical Oncology (2018)

  9. No Access

    Article

    Anti-cell growth and anti-cancer stem cell activities of the non-canonical hedgehog inhibitor GANT61 in triple-negative breast cancer cells

    Triple-negative breast cancer (TNBC) exhibits biologically aggressive behavior and has a poor prognosis. Novel molecular targeting agents are needed to control TNBC. Recent studies revealed that the non-canoni...

    Yoshikazu Koike, Yusuke Ohta, Wataru Saitoh, Tetsumasa Yamashita in Breast Cancer (2017)

  10. Article

    The current topics of surgical pathology of breast cancer in Japan

    Takuya Moriya in Breast Cancer (2016)

  11. No Access

    Article

    Immunocytochemical results for HER2 and Ki67 in breast cancer touch-smear cell specimens are reliable

    Re-evaluation of the subtype of recurrent breast cancer is necessary for deciding the treatment approach, but it is often not performed due to the difficulty of obtaining tissue specimens from a recurrent lesi...

    Masami Morimoto, Yoshimi Bando, Misako Nakagawa, Hirokazu Takechi in Breast Cancer (2016)

  12. No Access

    Article

    Antitumor and anticancer stem cell activities of eribulin mesylate and antiestrogens in breast cancer cells

    Eribulin mesylate (eribulin), a non-taxane microtubule dynamic inhibitor, has been widely used in the treatment of patients with advanced or metastatic breast cancer. The combined antitumor and anticancer stem...

    Junichi Kurebayashi, Naoki Kanomata, Tetsumasa Yamashita, Toshiro Shimo in Breast Cancer (2016)

  13. No Access

    Article

    Emergent laparoscopic cholecystectomy for acute acalculous cholecystitis revisited

    To compare the safety of emergent laparoscopic cholecystectomy for acute acalculous cholecystitis (AAC) with surgery for acute calculous cholecystitis (ACC).

    Daisuke Ueno, Hiroshi Nakashima, Masaharu Higashida, Koji Yoshida in Surgery Today (2016)

  14. No Access

    Article

    Assessment of the Ki67 labeling index: a Japanese validation ring study

    A lack of consistent methods to evaluate Ki67 expression is problematic in terms of accurately predicting prognosis in breast cancer. Accordingly, this study aimed to identify the causes of discrepancies in Ki...

    Naoki Niikura, Takashi Sakatani, Nobuyuki Arima, Yasuyo Ohi, Naoko Honma in Breast Cancer (2016)

  15. No Access

    Article

    Prognostic value of phosphorylated HER2 in HER2-positive breast cancer patients treated with adjuvant trastuzumab

    Adjuvant trastuzumab has been routinely used in HER2-positive operable breast cancer patients. Prognostic factors remain to be well characterized in these patients and might correlate with primary and/or acqui...

    Junichi Kurebayashi, Naoki Kanomata, Tetsumasa Yamashita, Toshiro Shimo in Breast Cancer (2015)

  16. No Access

    Article

    IgG4-related disease of the breast: a systemic disease whose mammary manifestations mimic breast cancer

    IgG4-related disease is a newly identified disease entity that has begun to attract attention, and international consensus diagnostic criteria for the condition have recently been proposed. The characteristic ...

    Takuya Moriya, Hisashi Hirakawa, Maki Nagashima in International Cancer Conference Journal (2015)

  17. No Access

    Article

    Visual assessment of Ki67 at a glance is an easy method to exclude many luminal-type breast cancers from counting 1000 cells

    The Ki67 labeling index (LI) reflects the proliferative activity of breast cancers and defines luminal A and B tumors; however, no detailed method to measure Ki67 has been standardized. Here, we propose a fast...

    Akira I. Hida, Yumi Oshiro, Hiromichi Inoue, Hidetoshi Kawaguchi in Breast Cancer (2015)

  18. No Access

    Article

    Marked lymphovascular invasion, progesterone receptor negativity, and high Ki67 labeling index predict poor outcome in breast cancer patients treated with endocrine therapy alone

    Whether postoperative chemotherapy should be added to endocrine therapy or not is an important issue in patients with hormone receptor-positive and human epidermal growth factor receptor (HER)2-negative breast...

    Junichi Kurebayashi, Naoki Kanomata, Toshiro Shimo, Tetsumasa Yamashita in Breast Cancer (2014)

  19. No Access

    Article

    Antitumor and anticancer stem cell activity of a poly ADP-ribose polymerase inhibitor olaparib in breast cancer cells

    Although the poly adenosine diphosphate (ADP)-ribose polymerase (PARP) inhibitor olaparib is known to have potent antitumor activity in BRCA-related breast cancer cells, a limited number of preclinical and cli...

    Toshiro Shimo, Junichi Kurebayashi, Naoki Kanomata, Tetsumasa Yamashita in Breast Cancer (2014)

  20. Article

    Intratumoral Estrogen Concentration and Expression of Estrogen-Induced Genes in Male Breast Carcinoma: Comparison with Female Breast Carcinoma

    It is speculated that estrogens play important roles in the male breast carcinoma (MBC) as well as the female breast carcinoma (FBC). However, estrogen concentrations or molecular features of estrogen actions ...

    Kiyoshi Takagi, Takuya Moriya, Masafumi Kurosumi, Kimako Oka in Hormones and Cancer (2013)

previous disabled Page of 3